Corticotropin-releasing factor: Began Phase I/II, open-label, dose-escalation trial in nine patients hospitalized with acute asthma. Following this trial, an ad

Neurobiological Technologies Inc. (NTII), Richmond, Calif.
Product:

Read the full 73 word article

How to gain access

Continue reading with a
two-week free trial.